Massmedica S.A. (WSE:MSM)
Poland · Delayed Price · Currency is PLN 5.70
+0.42 (7.95%)
At close: Sep 9, 2026
Massmedica Revenue
Massmedica had revenue of 7.31M PLN in the quarter ending June 30, 2026, a decrease of -1.60%. This brings the company's revenue in the last twelve months to 31.77M, up 8.91% year-over-year. In the year 2025, Massmedica had annual revenue of 32.22M, down -1.20%.
Revenue (ttm)
31.77M
Revenue Growth
+8.91%
P/S Ratio
0.40
Revenue / Employee
n/a
Employees
14
Market Cap
12.75M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.22M | -389.86K | -1.20% |
| Dec 31, 2024 | 32.61M | 6.22M | 23.56% |
| Dec 31, 2023 | 26.39M | 1.57M | 6.31% |
| Dec 31, 2022 | 24.83M | 6.63M | 36.47% |
| Dec 31, 2021 | 18.19M | - | - |
| Dec 31, 2020 | 18.19M | -563.84K | -3.01% |
| Dec 31, 2019 | 18.76M | -742.36K | -3.81% |
| Dec 31, 2018 | 19.50M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Verbicom | 48.85M |
| Werth-Holz | 29.17M |
| Polman | 23.71M |
| JRC Group | 17.94M |
| Przedsiebiorstwa Telekomunikacyjnego TELGAM | 6.45M |
| Danks Spólka Akcyjna | 3.98M |
| NPL Nova | 3.09M |
| Biomass Energy Project | 2.42M |